ANN GRAHAM ZAUBER

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Cost-effectiveness of colonoscopy
    Ann G Zauber
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 East 63rd Street, Room 357, New York, NY 10065, USA
    Gastrointest Endosc Clin N Am 20:751-70. 2010
  2. ncbi Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths
    Ann G Zauber
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    N Engl J Med 366:687-96. 2012
  3. ncbi Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force
    Ann G Zauber
    Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Ann Intern Med 149:659-69. 2008
  4. ncbi Implications of new colorectal cancer screening technologies for primary care practice
    Ann G Zauber
    Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA
    Med Care 46:S138-46. 2008
  5. ncbi Variants in hormone biosynthesis genes and risk of endometrial cancer
    Sara H Olson
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA
    Cancer Causes Control 19:955-63. 2008
  6. ncbi Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer
    Sara H Olson
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer Detect Prev 31:345-51. 2007
  7. ncbi Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society
    Sidney J Winawer
    Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Gastroenterology 130:1872-85. 2006
  8. ncbi The advanced adenoma as the primary target of screening
    Sidney J Winawer
    Department of Medicine, Memorial Sloan Kettering Cancer Center, and Weill Medical College of Cornell University, New York, New York 10021, USA
    Gastrointest Endosc Clin N Am 12:1-9, v. 2002
  9. ncbi Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society
    Sidney J Winawer
    Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    CA Cancer J Clin 56:143-59; quiz 184-5. 2006
  10. ncbi Risk of endometrial cancer in relation to medical conditions and medication use
    Joan Fortuny
    Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer Epidemiol Biomarkers Prev 18:1448-56. 2009

Research Grants

  1. SCREENING COLONOSCOPY FEASIBILITY TRIAL
    Ann Zauber; Fiscal Year: 2009
  2. SCREENING COLONOSCOPY FEASIBILITY TRIAL
    ANN GRAHAM ZAUBER; Fiscal Year: 2010

Detail Information

Publications22

  1. ncbi Cost-effectiveness of colonoscopy
    Ann G Zauber
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 East 63rd Street, Room 357, New York, NY 10065, USA
    Gastrointest Endosc Clin N Am 20:751-70. 2010
    ..Computed tomographic colonography was not a cost-effective strategy. Stool DNA testing was not assessed in the analysis for this article...
  2. ncbi Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths
    Ann G Zauber
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    N Engl J Med 366:687-96. 2012
    ..In the National Polyp Study (NPS), colorectal cancer was prevented by colonoscopic removal of adenomatous polyps. We evaluated the long-term effect of colonoscopic polypectomy in a study on mortality from colorectal cancer...
  3. ncbi Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force
    Ann G Zauber
    Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Ann Intern Med 149:659-69. 2008
    ..The U.S. Preventive Services Task Force requested a decision analysis to inform their update of recommendations for colorectal cancer screening...
  4. ncbi Implications of new colorectal cancer screening technologies for primary care practice
    Ann G Zauber
    Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA
    Med Care 46:S138-46. 2008
  5. ncbi Variants in hormone biosynthesis genes and risk of endometrial cancer
    Sara H Olson
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA
    Cancer Causes Control 19:955-63. 2008
    ..01). The insertion/deletion variant in CYP19A1 appears to be related to risk of endometrial cancer; risk associated with variants in this gene may vary according to BMI...
  6. ncbi Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer
    Sara H Olson
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer Detect Prev 31:345-51. 2007
    ..Although genes have been identified that are critical in allergic response, polymorphisms in these genes have not been studied in relation to risk of pancreatic cancer. We hypothesized that variants in these genes are related to risk...
  7. ncbi Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society
    Sidney J Winawer
    Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Gastroenterology 130:1872-85. 2006
    ..It has been shown that the first screening colonoscopy and polypectomy produces the greatest effects on reducing the incidence of colorectal cancer in patients with adenomatous polyps...
  8. ncbi The advanced adenoma as the primary target of screening
    Sidney J Winawer
    Department of Medicine, Memorial Sloan Kettering Cancer Center, and Weill Medical College of Cornell University, New York, New York 10021, USA
    Gastrointest Endosc Clin N Am 12:1-9, v. 2002
    ....
  9. ncbi Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society
    Sidney J Winawer
    Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    CA Cancer J Clin 56:143-59; quiz 184-5. 2006
    ..It has been shown that the first screening colonoscopy and polypectomy produces the greatest effects on reducing the incidence of colorectal cancer in patients with adenomatous polyps...
  10. ncbi Risk of endometrial cancer in relation to medical conditions and medication use
    Joan Fortuny
    Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer Epidemiol Biomarkers Prev 18:1448-56. 2009
    ..9). Use of nonsteroidal anti-inflammatory drugs was related to a decreased risk (OR, 0.7; 95% CI, 0.5-0.97). To our knowledge, the observation about thiazide diuretics is novel and requires confirmation in other studies and populations...
  11. ncbi Colonoscopy surveillance after polypectomy and colorectal cancer resection
    Durado D Brooks
    American Cancer Society, Atlanta, Georgia, USA
    Am Fam Physician 77:995-1002. 2008
    ....
  12. ncbi Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization
    Diana L Miglioretti
    Group Health Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    Med Care 46:S91-6. 2008
    ....
  13. ncbi Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas
    Scott D Solomon
    Cardiovascular Division, Brigham and Women s Hospital, Boston, Mass 02115, USA
    Circulation 114:1028-35. 2006
    ..Cyclooxygenase-2 (COX-2) inhibitors have been shown to reduce colorectal adenomas but have been associated with increased cardiovascular risk...
  14. ncbi High-quality colonoscopies must be an integral part of screening and surveillance programs
    Ann G Zauber
    Gastroenterology 130:620-1; author reply 621-2. 2006
  15. ncbi Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms
    N Peter Zauber
    Department of Medicine, Saint Barnabas Medical Center, Livingston, New Jersey, USA
    Cancer 104:719-29. 2005
    ....
  16. ncbi Flat adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially or during surveillance?
    Michael J O'Brien
    Department of Pathology, Boston Medical Center, Boston, Massachusetts 02118, USA
    Clin Gastroenterol Hepatol 2:905-11. 2004
    ..Sessile adenomas from the National Polyp Study cohort were reclassified histopathologically as flat or polypoid and compared with initial and surveillance pathology...
  17. ncbi National Polyp Study data: evidence for regression of adenomas
    Franka Loeve
    Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Int J Cancer 111:633-9. 2004
    ..This lowers the expectations for the effects of colorectal cancer screening strategies that focus on adenoma detection...
  18. ncbi Celecoxib for the prevention of colorectal adenomatous polyps
    Nadir Arber
    Integrated Cancer Prevention Center, Tel Aviv Sourasky Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    N Engl J Med 355:885-95. 2006
    ..65 to 2.62). CONCLUSIONS: The use of 400 mg of celecoxib once daily significantly reduced the occurrence of colorectal adenomas within three years after polypectomy. (ClinicalTrials.gov number, NCT00141193 [ClinicalTrials.gov].)...
  19. ncbi Celecoxib for the prevention of sporadic colorectal adenomas
    Monica M Bertagnolli
    Brigham and Women s Hospital, Boston, USA
    N Engl J Med 355:873-84. 2006
    ....
  20. ncbi How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment
    Iris Vogelaar
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, The Netherlands
    Cancer 107:1624-33. 2006
    ..This study assessed the potential reduction in CRC mortality that may be achieved through further dissemination of current interventions for risk-factor modification, screening, and treatment...
  21. ncbi Quality control for flexible sigmoidoscopy: which polyps count?
    Ann G Zauber
    Gastroenterology 126:1474-7. 2004
  22. ncbi On finding flat adenomas: is the search worth the gain?
    Ann G Zauber
    Gastroenterology 122:839-40. 2002

Research Grants2

  1. SCREENING COLONOSCOPY FEASIBILITY TRIAL
    Ann Zauber; Fiscal Year: 2009
    ....
  2. SCREENING COLONOSCOPY FEASIBILITY TRIAL
    ANN GRAHAM ZAUBER; Fiscal Year: 2010
    ....